Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Repligen Cp (RGEN)

Repligen Cp (RGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,184,167
  • Shares Outstanding, K 52,503
  • Annual Sales, $ 270,250 K
  • Annual Income, $ 21,410 K
  • 60-Month Beta 1.14
  • Price/Sales 30.41
  • Price/Cash Flow 111.03
  • Price/Book 7.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.27
  • Number of Estimates 5
  • High Estimate 0.31
  • Low Estimate 0.25
  • Prior Year 0.26
  • Growth Rate Est. (year over year) +3.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.12 +29.77%
on 07/14/20
159.97 -2.56%
on 08/03/20
+29.23 (+23.08%)
since 07/02/20
3-Month
109.38 +42.51%
on 06/25/20
159.97 -2.56%
on 08/03/20
+41.36 (+36.12%)
since 05/05/20
52-Week
72.32 +115.54%
on 10/02/19
159.97 -2.56%
on 08/03/20
+69.03 (+79.48%)
since 08/05/19

Most Recent Stories

More News
Look for Shares of Repligen Corp to Potentially Pullback after Yesterday's 5.56% Rise

Repligen Corp (NASDAQ:RGEN) traded in a range yesterday that spanned from a low of $152.46 to a high of $159.70. Yesterday, the shares gained 5.6%, which took the trading range above the 3-day high of...

RGEN : 155.88 (-0.42%)
Repligen (RGEN) Hits Fresh High: Is There Still Room to Run?

Repligen (RGEN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

RGEN : 155.88 (-0.42%)
BMY : 59.69 (+0.37%)
OSMT : 5.59 (-1.58%)
TLSA : 5.44 (-3.20%)
After Yesterday's Rally of 6.55% Shares Could Potentially Pullback

Repligen Corp (NASDAQ:RGEN) traded in a range yesterday that spanned from a low of $142.54 to a high of $155.27. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of...

RGEN : 155.88 (-0.42%)
Repligen (RGEN) Q2 Earnings and Revenues Top Estimates

Repligen (RGEN) delivered earnings and revenue surprises of 50.00% and 11.98%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

RGEN : 155.88 (-0.42%)
Repligen: 2Q Earnings Snapshot

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported second-quarter profit of $15.9 million.

RGEN : 155.88 (-0.42%)
NASDAQ, S&P Gain Over 1% as Fed Continues Support

NASDAQ, S&P Gain Over 1% as Fed Continues Support

BABA : 264.91 (+1.03%)
TCEHY : 72.4500 (+1.77%)
RGEN : 155.88 (-0.42%)
PNR : 43.61 (+1.18%)
MCHP : 98.50 (-8.22%)
CSCO : 47.33 (-0.71%)
CMC : 21.67 (+1.36%)
TSLX : 17.65 (unch)
CRTO : 14.36 (+0.98%)
USX : 9.51 (+1.93%)
NFLX : 502.11 (-1.48%)
AAPL : 440.25 (+0.36%)
FB : 249.12 (-0.28%)
AMZN : 3,205.03 (+2.11%)
GOOG : 1,473.61 (+0.59%)
AMD : 85.31 (+0.32%)
Repligen Corp Falls 2.33% on Heavy Volume: Watch For Potential Rebound

Repligen Corp (NASDAQ:RGEN) traded in a range yesterday that spanned from a low of $132.03 to a high of $134.69. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $133.76...

RGEN : 155.88 (-0.42%)
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for

Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RGEN : 155.88 (-0.42%)
Has Repligen (RGEN) Outpaced Other Medical Stocks This Year?

Is (RGEN) Outperforming Other Medical Stocks This Year?

RGEN : 155.88 (-0.42%)
EXEL vs. RGEN: Which Stock Should Value Investors Buy Now?

EXEL vs. RGEN: Which Stock Is the Better Value Option?

EXEL : 23.05 (-1.71%)
RGEN : 155.88 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade RGEN with:

Business Summary

Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide....

See More

Key Turning Points

2nd Resistance Point 159.46
1st Resistance Point 157.67
Last Price 155.88
1st Support Level 154.43
2nd Support Level 152.98

See More

52-Week High 159.97
Last Price 155.88
Fibonacci 61.8% 126.49
Fibonacci 50% 116.15
Fibonacci 38.2% 105.80
52-Week Low 72.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar